Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies Inc (NASDAQ: ACLS) delivers critical ion implantation systems and semiconductor manufacturing solutions to leading global chipmakers. This page provides investors and industry professionals with a centralized hub for official company announcements, operational updates, and strategic developments.
Access timely updates including earnings reports, product launches, technology partnerships, and service expansions. Our curated collection ensures you stay informed about ACLS's role in advanced logic, silicon carbide processing, and semiconductor equipment innovation.
Discover press releases covering operational milestones, customer collaborations, and advancements in process control technologies. All content is verified for accuracy and relevance to support informed analysis of ACLS's market position and industry contributions.
Bookmark this page for direct access to Axcelis Technologies' latest news. Check regularly for updates on equipment deployments, aftermarket service initiatives, and strategic developments shaping semiconductor manufacturing.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its financial results for Q1 2023 on May 3, 2023, at 4:00 p.m. ET, followed by a conference call on May 4, 2023, at 8:30 a.m. ET. Interested parties can access the call via an audio webcast on Axcelis' Investors page. The company, headquartered in Beverly, Massachusetts, specializes in high-productivity solutions for the semiconductor industry, focusing on ion implantation systems and complete life cycle support. For more information, visit www.axcelis.com.
Axcelis Technologies (Nasdaq: ACLS) announced the significant milestone of shipping its 500th Purion™ ion implanter system to a major semiconductor manufacturer in North America. This achievement underscores Axcelis' market leadership in providing ion implantation solutions for the semiconductor industry. According to President and CEO Mary Puma, this shipment validates the company’s strong customer partnerships and expanding manufacturing capabilities. The growing installed base of Purion systems is expected to bolster Axcelis' aftermarket business. The Purion platform is recognized for its advanced technology, particularly in image sensor and power device manufacturing.
Axcelis Technologies (Nasdaq: ACLS) has appointed Russell J. Low, Ph.D., as President and CEO effective May 11, 2023. He will succeed Mary G. Puma, who will become Executive Chairperson and remain a Senior Advisor. Dr. Low, previously Executive VP of Global Customer Operations and Engineering, played a key role in developing the Purion ion implant product line. Puma, who has led Axcelis for 22 years, emphasized the timing for this transition as ideal for future growth. The board expressed confidence in Dr. Low's leadership, highlighting his technical expertise and commitment to innovation, promising continued market leadership and value delivery.
FAQ
What is the current stock price of Axcelis Tech Ord (ACLS)?
What is the market cap of Axcelis Tech Ord (ACLS)?
